Clinical Trials Insight: 700048347

Trial Profile

Clinical Trials Insight: 700048347

Planning
Phase of Trial: Phase III

Latest Information Update: 19 Aug 2010

At a glance

  • Drugs Dexpramipexole (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Biogen
  • Most Recent Events

    • 19 Aug 2010 Biogen Idec is expected to initiate this trial in the first half of 2011, according to a media release.
    • 19 Aug 2010 Biogen Idec and Knopp Neurosciences have entered into a worldwide agreement under which Biogen Idec will develop and commercialise dexpramipexole, according to a Biogen Idec media release.
    • 03 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top